Mitchell & Pahl Private Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Mitchell & Pahl Private Wealth's AMGN Position: Q2 2026 in Review
Mitchell & Pahl Private Wealth increased its Amgen (AMGN) stake by 4.1% in Q2 2026, buying an estimated $95.8K and bringing the position to 7,175 shares worth $2.6M. The position accounts for 0.95% of the portfolio, ranked #40.
Mitchell & Pahl Private Wealth first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Mitchell & Pahl Private Wealth held 7,175 shares of Amgen worth $2.6M as of Q2 2026.
- Mitchell & Pahl Private Wealth bought 280 Amgen shares in Q2 2026, an estimated $95.8K.
- Amgen made up 0.95% of Mitchell & Pahl Private Wealth's portfolio in Q2 2026, its #40 holding.
- Mitchell & Pahl Private Wealth first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Mitchell & Pahl Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.